Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Gebel

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 31, 2011
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplantsW Dar, A Agarwal, C Watkins, et al.
Immunological Reviews|January 1, 1981
Occurrence and potential significance of increased numbers of T cells with Fc receptors in myelomaR G Hoover, H M Gebel, B K Dieckgraefe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individualsM Clerici, D R Lucey, R A Zajac, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Revisiting traditional risk factors for rejection and graft loss after kidney transplantationT B Dunn, H Noreen, K Gillingham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2014
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patientsR A Bray, P Brannon, C Breitenbach, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Transplanting the highly sensitized patient: The emory algorithmR A Bray, J D L Nolen, C Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5R W Karr, C C Kannapell, J A Stein, et al.
The Journal of Experimental Medicine|August 1, 1982
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresisR W Karr, C C Kannapell, J A Stein, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 31, 2011
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplantsW Dar, A Agarwal, C Watkins, et al.
Immunological Reviews|January 1, 1981
Occurrence and potential significance of increased numbers of T cells with Fc receptors in myelomaR G Hoover, H M Gebel, B K Dieckgraefe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individualsM Clerici, D R Lucey, R A Zajac, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Revisiting traditional risk factors for rejection and graft loss after kidney transplantationT B Dunn, H Noreen, K Gillingham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2014
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patientsR A Bray, P Brannon, C Breitenbach, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Transplanting the highly sensitized patient: The emory algorithmR A Bray, J D L Nolen, C Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5R W Karr, C C Kannapell, J A Stein, et al.
The Journal of Experimental Medicine|August 1, 1982
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresisR W Karr, C C Kannapell, J A Stein, et al.
Pageof 9